Valent BioSciences, ADAPCO Form Strategic Partnership in Public Health

FOR IMMEDIATE RELEASE

Relationship includes an exclusive distribution agreement for US markets

Libertyville, IL, August 29, 2018 — Valent BioSciences (VBC), the global leader in biorational solutions for public health, forest health, and agriculture, announced it has entered into a strategic partnership with ADAPCO, the world’s largest distributor of products to the professional mosquito control industry. As part of the agreement, ADAPCO will become the exclusive distributor of VBC’s broad range of biological-based mosquito control technologies in the US, Puerto Rico, and the Cayman Islands.

The move aligns two of Public Health’s most respected companies in an effort to better serve vector management programs across the US and Caribbean.

“This partnership creates an exciting future for VBC’s Public Health business, its customers, and the people we protect,” said Steve Krause, Global Business Director for VBC’s Public Health and Forestry businesses. “We operate in a highly technical industry, and ADAPCO’s proven history of excellence in the design and operation of equipment, field support, customer service, and the handling of our solutions made it a clear choice going forward.”

Krause indicates the partnership blossomed through ADAPCO’s work with VBC’s award winning technology across five Western states. VBC won a 2017 Chicago Innovation Award for its Wide Area Larvicide Spray (WALS™) application technology. Developed through more than 20 years of global research, WALS leverages VectoBac®, VBC’s advanced Bacillus thuringiensisspp. israelensisStrain AM65-52 (Bti) technology using a breakthrough method for delivering biorational larvicides into the hard-to-reach areas where Dengue- and Zika-transmitting mosquitoes breed.

“We are excited to foster a new era of vector control and mosquito suppression,” said Steve Burt, Managing Director, Specialty Ag/Hort, Azelis Americas. “This alignment of industry-leading teams – Valent Biosciences’ leadership in the space of biorational larvicides, together with ADAPCO’s field and application expertise – will usher in a transformational future for vector control in these regions.”

The effective date for the distribution agreement is October 1, 2018.

# # #

About Valent BioSciences

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorationalproducts with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About ADAPCO

Headquartered in Sanford, FL, ADAPCO is an Azelis Americas company. ADAPCO© is the world’s largest distributor of innovative insecticide products, technology, and equipment to the professional mosquito control industry. Azelis is a leading global specialty chemicals distributor, providing a diverse range of products and innovative services to more than 40,000 customers. ADAPCO operates with maximum regard for the user, consumer, and the environment to protect human health. For additional information, visit the company’s website at www.myadapco.com.

Media Contacts:

Rick Melnick
Valent BioSciences
847-968-4750

Email: rick.melnick@valentbiosciences.com

Terry Mullin
ADAPCO
203-883-1477

E-Mail: terry.mullin@azelisamericas.com

Download News Release

Valent BioSciences Unveils New Biorational Research Center

FOR IMMEDIATE RELEASE

Grand Opening event attracts attendees from around the world to tour high tech facility

Libertyville, IL, July 25, 2018 — Valent BioSciences (VBC) officially opened the doors of its new global research facility, the Biorational Research Center (BRC), at a July 24thgala at Libertyville’s stylish Innovation Park. More than 250 guests, ranging from the Deputy Governor of the State of Illinois, to strategic partners, customers, allied industry representatives, and leading members of the scientific community gathered to join Grand Opening festivities and tour the 85,000 square-foot facility adjacent to the company’s long-time headquarters.

The opening of the BRC completes a two-year build-out and transition from VBC’s legacy research facility in nearby Long Grove, IL. The facility boasts approximately 65,000 square-feet of open-concept lab and office space combined with a state-of-the-art, 20,000 square-foot greenhouse. In addition to its technological upgrades, the move is intended to streamline cross-functional collaboration among VBC’s industry-leading team of innovative plant, soil, and formulation scientists, microbiologists, entomologists, and chemists – a team that brings best-in-class solutions to agriculture, public health, and forest health professionals around the world.

“This breathtaking new facility is a testimony to the notable success of our R&D group,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “All patents and awards aside, that success ultimately comes down to an ability to develop and commercialize sustainable products that deliver clear value to our stakeholders – whether they be growers, food companies, foresters, or governments that fight against insect-borne disease.”

The BRC is the latest addition to the Sumitomo Chemical Company (SCC) Biorational Research Network (BRN), a strategic enterprise that includes both internal resources and external (3rdparty) expertise. As the parent company to VBC, SCC deploys a global team of scientists operating in lab and field research facilities at key locations around the globe. Central to the BRN mission are investigations that brings together biorational and conventional technologies that work in harmony with nature.

The opening of the BRC is another in a string of investments VBC has made into its burgeoning biorational business over recent years. In addition to the acquisition of Pace International (2012) and Mycorrhizal Applications (2015), VBC also opened its Iowa-based $150 million biorational manufacturing plant in 2014, the first ever purpose-built biorational facility in the world.

# # #

About Valent BioSciences

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorationalproducts with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

Media Contact:

Rick Melnick
Valent BioSciences
847-968-4750

Email: rick.melnick@valentbiosciences.com

Download News Release

Valent BioSciences is Named Winner of Chicago Innovation Award for VectoBac® WDG and WALS™ Application Platform

FOR IMMEDIATE RELEASE

Breakthrough technology plays significant role in fight against Zika virus

Chicago, IL—  Valent BioSciences (VBC) of Libertyville, IL has been named a winner of the 16th annual Chicago Innovation Awards for the combined impact of VectoBac®WDG and the company’s proprietary Wide Area Larvicide Sprays (WALS™) application platform in the global fight against Zika virus.

The winners were announced at an event held at Chicago’s Harris Theater on Monday, October 30, with nearly 1500 business and civic leaders, and supporters of innovation in attendance. Celebrating its 16th year, the awards program is the Chicago region’s foremost recognition of the most innovative new products or services brought to market or to public service each year.

Developed through more than 20 years of global research, WALS leverages VBC’s advanced Bacillus thuringiensisspp. israelensisStrain AM65-52 (Bti) technology and establishes a breakthrough method for delivering biorational larvicides into the hard-to-reach areas where Zika-transmitting Aedesmosquitoes breed. In 2016, when the first locally acquired cases of Zika in the U.S. were detected in Florida, VectoBac and WALS helped Miami-Dade public health officials become the first mosquito control district ever to break the transmission cycle of the devastating disease.

“This prestigious award highlights the combined abilities of our team in areas ranging from research, formulation science, manufacturing, field operationsand marketing,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “The active role that our products and technologies play in protecting human potential is something that we take great pride in.”

Over 530 organizations were nominated for this year’s awards, and as a group generated record totals in economic output along with the creation of over 15,000 new jobs. Winning organizations receive a variety of honors including the opportunity to ring the NASDAQ Bell in New York City, and meetings with the Mayor, Governor and Cook County President.

The WALS platform has global reach and is being implemented successfully by VBC and affiliates in Latin America and SE Asia to combat Zika and other Aedes-vectored diseases including dengue fever. VBC Director of Global Health Steve Krause, who accepted the award, said that the company’s commitment to global health and sustainable development is a key driver its business.

“Success stories like WALS and the fight against Zika are a testament not only to what we can accomplish as a company, but to the importance that public and private partnerships play in responding to global health threats,” said Krause. “By working closely with federal and local governments, VBC helps address these needs by providing research, technology development, and the field level support necessary to bring these technologies to communities in need. It is a collaborative approach that brings together some of the most experienced minds in Public Health, which in turn result in key innovations like WALS and VectoBac WDG.”

The complete list of this year’s Chicago Innovation Award winners can be found at www.chicagoinnovation.com.

# # #

About Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorationalproducts with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

 

Media Contact:

Rick Melnick
Valent BioSciences
847-968-4750

Email: rick.melnick@valentbiosciences.com

Download News Release

Valent BioSciences Corporation Reaches Distribution Deal for Actinovate® Brands with The BioAg Alliance

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL, January, 19, 2016 – Valent BioSciences Corporation (VBC) announced it has reached an agreement with The BioAg Alliance to distribute certain Actinovate® Biological Fungicide products. Through the agreement, Actinovate® AG brand sales for the United States will be handled through Valent U.S.A. Corporation and for Canada by Valent Canada, Inc.

Actinovate® AG is a broad spectrum biofungicide product for management of common foliar and soilborne diseases found on outdoor crops and in greenhouses, nurseries, and turf. The move aims to further strengthen the Valent Group’s biorational offering while leveraging its substantial penetration into the biocontrol and disease management market.

“We are pleased to add a quality product such as Actinovate® AG to our industry- leading biorational product line,” said Ted Melnik, executive vice president and chief operating officer of VBC. “Actinovate® AG is a proven product that offers growers a flexible tool for fighting disease and managing resistance while providing value across a wide range of plants and crops.”

“The BioAg Alliance is pleased to work with Valent BioSciences to deliver this new solution to their customers,” said Brad Griffith, Vice President of Global Microbials for Monsanto. “We are focused on being the preferred development and commercial partner in ag microbials worldwide, bringing value to our partners and this agreement is a great example of this work. The BioAg Alliance brings an unmatched ability to take ag microbial products from idea to market – including access to premier formulation, testing, production, and regulatory capabilities.”

The deal comes on the heels of VBC’s recent acquisition of Mycorrhizal Applications and its 2012 acquisition of Pace International. Valent U.S.A. and other affiliates of parent Sumitomo Chemical Company, Limited are closely aligning development of conventionals and biorationals to further strengthen their global crop protection and enhancement businesses.

Valent U.S.A. executive vice president and chief operating officer Matt Plitt said “The Actinovate® AG deal builds on the company’s goal to provide growers with an integrated portfolio of valuable plant protection tools.”

A broad spectrum biofungicide product, Actinovate® AG Biological Fungicide, offers growers with an excellent option for multiple growing practices, including organic, sustainable or conventional production systems. Actinovate® AG is OMRI-approved with the lowest possible re-entry interval and zero day preharvest interval, giving growers flexibility to fit their production plan.

“Growers are looking for smart technologies from planting all the way through to postharvest uses,” Plitt said. “Actinovate® AG products are a good fit for our balanced portfolio that leverages the benefits of biorational and conventional products in an integrated program to bring out the best in every plant.”

The distribution agreement includes outdoor crops, greenhouse, nursery and turf uses of the Actinovate® AG brands – Actinovate® AG, Actinovate® L&G, Actinovate® SP and Actino-Iron®. Mycorrhizal Applications will also distribute Actino Iron as an ingredient into the specialty potting soil market. Seed treatment uses will be retained by the BioAg Alliance.

For more information about Actinovate® visit www.valent.com or www.valent.ca.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation. For additional information, visit the company’s website at www.valent.com

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated net sales for fiscal year 2014 were JPY 2.38 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About The BioAg Alliance
First announced in December 2013, The BioAg Alliance is unique in the industry, bringing together Novozymes’ BioAg operations and capabilities within microbial discovery, development and production with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities. The result is a comprehensive discovery, development and commercial collaboration to help farmers globally meet the challenge of producing more with less in a sustainable way – for the benefit of agriculture, consumers, the environment and society at large.

Media Contacts:
Valent BioSciences Corporation
Rick Melnick
847-968-4750
Email: rick.melnick@valentbiosciences.com

The BioAg Alliance
Johan Melchior,
Novozymes
+45-3077-0690
Email: jmel@novozymes.com

Lee Quarles, Monsanto
314-694-6397
Email: lee.quarles@monsanto.com

Actino-Iron is a registered trademark of Novozymes A/S. Actinovate is a trademark of Monsanto Technology, LLC.

Download News Release

Valent BioSciences Corporation Acquires Mycorrhizal Applications, Inc.

FOR IMMEDIATE RELEASE

Industry leader adds innovative technology platform to further expand its rapidly growing biorational business

LIBERTYVILLE, IL, March 4, 2015 – Valent BioSciences Corporation (VBC), the leader in biorational product development for agriculture, public health, and forestry worldwide, announced today it has acquired Mycorrhizal Applications, Inc. (MA), the world’s largest producer of mycorrhizal fungal inoculum. Mycorrhizal inoculation increases plant productivity by forming a symbiotic relationship with plant roots. Mycorrhizal hyphae attach to roots and radiate out into soil, enhancing access to nutrients and water made available to plants.

The acquisition adds another strategic platform to VBC’s rapidly expanding global biorational business, providing additional tools for the Biorational Window platform being developed with its parent, Sumitomo Chemical Co., Ltd. (SCC).

“The acquisition of Mycorrhizal Applications will allow us to accelerate the development of our rhizosphere strategy and immediately reinforce our strength in the biorational business,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “The move affords us the unique opportunity to leverage our internal resources and develop an entire suite of innovative rhizosphere products and technologies that expands our portfolio to meet the needs of growers around the world.”

Founded in 1995 and headquartered in Oregon, MA’s earliest products were developed for forestry and nursery applications. Nearly 90% of the world’s plants form an association with mycorrhizal fungi, which colonize plant roots and provide the host with enhanced capacity for water and mineral uptake. In exchange, the fungi benefit from access to plant carbohydrates, which they use for food. Today, MA’s business has grown to include products for commercial agriculture, manufactured soils, turf, landscape and restoration.

The company’s leading brand, MycoApply®, is sold in powder, granular, and liquid form. Melnik said a dedicated R&D budget, earmarked for rhizosphere product development, has been established to coincide with the acquisition. VBC anticipates a host of new uses, with widespread agricultural applications, being developed in the next few years. Globally, MycoApply® will be sold through the SCC affiliate network. Valent U.S.A.

Corporation will handle commercialization of the Mycorrhizal Applications pipeline and portfolio in Agricultural crops in the NAFTA region, including marketing, product development and sales through associated distribution networks. With this innovative platform technology, Valent U.S.A. will create crop protection and enhancement solutions that complement its existing portfolio to deliver more value to its customers.

“We’re very excited to become part of the VBC and SCC family,” said Dr. Mike Amaranthus, the renowned rhizosphere scientist who co-founded the business with wife, Eileen. “While we will provide our customers with the same quality products and expert support they’ve come to expect from us, VBC’s investment will further accelerate our innovation and increase our capacity to meet the growing demand for our products and food and fiber, globally. Our goal is to make mycorrhizal inoculation an essential tool to increase plant productivity while improving the quality of our lives and the environment. VBC provides the fundamental capacity for achieving that goal.”

Johan Pienaar, Global Business Manager for VBC’s plant growth regulator business, will become the new Chief Operating Officer of MA, reporting directly to Ted Melnik. Pienaar will operate out of the Grants Pass office.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Mycorrhizal Applications, Inc.
Headquartered in Grants Pass, OR, Mycorrhizal Applications Inc. (MA) grows mycorrhizal seeds, or “spores,” used to produce mycorrhizal plants that improve soil health and increase nutrient and water uptake and efficiency. Working hand-in hand with the forestry, agricultural, ornamental, turf, and nursery industries, MA prides itself in its commitment to sustainability, customer service, and quality products based on and sound science. For additional information, visit the company’s website at http://mycorrhizae.com/

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of basic chemicals, petrochemicals, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2013 were JPY 2.24 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

U.S. EPA Approves New VectoPrime™ Biological Larvicide for Single-brood Floodwater Mosquito Larvae Programs

FOR IMMEDIATE RELEASE

Breakthrough dual-action larvicide provides effective control in all four instar stages for all mosquito species

LIBERTYVILLE, IL, February, 24, 2015 – Valent BioSciences Corporation (VBC) announced that the U.S. Environmental Protection Agency (EPA) has granted registration approval for VectoPrimeTM Biological Larvicide for single-brood mosquito control. Through the power of BioFuseTM technology, VectoPrime is formulated with a specific ratio of Bacillus thuringiensis spp. israelensis Strain AM65-52 and (S)- methoprene developed through years of painstaking research. The result is a unique combination of efficacy, flexibility, and efficiency benefits to support U.S.-based mosquito abatement professionals.

The dual action of VectoPrime provides control from pre-hatch applications all the way through the 4th instar while delivering a host of related benefits. Asynchronous broods pose a significant challenge in the ongoing battle against mosquitos capable of transmitting harmful diseases such as West Nile virus, dengue fever, malaria, and encephalitis.

“The advanced technology and extended application window offered by VectoPrime allows Mosquito Abatement Districts to plan more and react less,” said Steve Krause, VBC’s Global Business Manager for Public Health and Forestry. “VectoPrime provides Districts the opportunity to streamline their process through lower application rates, which in turn translate into enhanced inventory management, greater agility, and greater value for mosquito control programs at the ground level.”

BioFuse is VBC’s patented formulation technology that combines precise amounts of two active ingredients within the space of a single microparticle. With VectoPrime, both active ingredients are released instantly upon contact with water to provide applicators with immediate, visible proof that mosquito larvae are dead. The product’s reduced application rates drive further operational efficiencies that result in savings on fuel, maintenance, and labor.

VectoPrimeTM joins VBC’s biorational mosquito larvicides VectoBac®, VectoMax®, MetaLarv®, VectoLex®, and Teknar® to provide the public health industry’s most comprehensive range of target-specific, biorational larvicides for mosquito abatement professionals and health care officials around the globe.

For more information about VectoPrimeTM or any other target-specific, biorational mosquito larvicides, visit http://publichealth.valentbiosciences.com/products/vectoprime

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Valent BioSciences Corporation Unveils its State-of-the-Art Biorational Manufacturing Facility in Osage, Iowa

FOR IMMEDIATE RELEASE

Grand opening event signifies a new era in integrated crop production

OSAGE, IA., June 27, 2014 – Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel. VBC is the global leader in the discovery, development, manufacturing, and commercialization of biorational products for agriculture, public health, and forestry.

Located on an expansive 73-acre site, the new 130,000 square foot plant is the largest purpose-built biorational facility in the world and will serve as the manufacturing and quality control center for VBC’s broad portfolio of fermentation products. VBC brands are derived from biological origins and provide economic, health, and environmental benefits for agriculture, public health, and forestry markets in 95 countries around the globe.

“This is a landmark day for Valent BioSciences, our parent Sumitomo Chemical Company (SCC), and for the entire biorational segment,” said Ted Melnik, VBC Executive Vice President and COO. “Not only does this investment reflect the rapid growth of our business and validate the value of biorational technology in the marketplace, it puts us in the position to meet the rising demand for our products as we continue to develop new and innovative solutions for our customers around the world.”

The opening of the new plant comes on the heels of VBC’s acquisition of Pace International, LLC (Pace), in early 2013 and its announcement of a long term strategic alliance with Biomar Microbial Technologies (Biomar) in February of this year. The Pace acquisition made SCC the first multinational supplier to offer both conventional and biorational product solutions for seed, preharvest crop production, and preharvest and postharvest crop protection applications. The Biomar alliance will create a new pipeline of industry leading, science-based products with additional work being conducted at Valent BioSciences’ research facility at Long Grove, IL.

VBC currently manufactures microbial insecticides, nematicides, and plant growth regulators used in production agriculture for managing plant growth, quality and stress in crops.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of basic chemicals, petrochemicals, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2013 were JPY 2.24 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Pace International LLC
Pace International LLC collaborates with growers, packers and agricultural organizations to develop innovative solutions to enhance, protect, and preserve fruit and vegetable quality. Pace is the leading provider of postharvest solutions and technologies, equipment and technical services to maximize efficiencies in packing operations and increase the value of crops being processed. Pace International LLC is headquartered in Wapato, Washington, USA with Sales and Technical Service Offices around the world. For more information, visit http://www.paceint.com

About Biomar Microbial Technologies
Headquartered in Leon, Spain, Biomar Microbial Technologies is an independent company specialized in marine biotechnology, with one of the world ́s largest collections of marine microorganisms. For additional information, visit the company’s website at www.biomarmicrobialtechnologies.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation 847-968-4750
Email: rick.melnick@valentbiosciences.com

Download News Release

Valent BioSciences Corporation Earns ISO 9001:2008 Re-certification Following a System-Wide Audit

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL., December 11, 2013 – Valent BioSciences Corporation is pleased to announce that its US-based operations have earned another three-year certification of compliance with ISO 9001:2008 standards. The certification comes as the result of a full, system-wide audit by Perry Johnson Registrars, Inc. (PJR), the first such audit since VBC achieved ISO-certification in 2010.

Valent BioSciences is a worldwide leader in the development and commercialization of biorational products. Biorationals are products typically derived from biological origins that are highly specific in their activity while providing economic, health, and/or environmental benefits. Biorational products include microbial insecticides, fungicides, and nematicides, as well as plant growth regulators used in production agriculture and for managing plant growth, quality and stress in crops.

“ISO-compliance puts VBC in a select group among biopesticide manufacturers,” said Ted Melnik, VBC Executive Vice President & Chief Operating Officer. “Our adherence to these standards reflects our firm commitment to delivering quality and value through our entire biorational portfolio to customers around the world.”

The company’s current certification applies to VBC’s management systems, and plans already are being discussed for pursuit of certification for the new state of the art biorational manufacturing facility in Osage, Iowa, scheduled to begin production in mid- 2014. Quality management of all manufacturing operations is critical to support biorational products, especially for companies such as VBC who have a truly global footprint.

This year’s audit results were particularly important – not only in terms of the auditors’ findings but also as validation for the company’s internal, continuous improvement process launched in 2010. VBC’s next full-systems audit is scheduled for 2016.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Download Press Release

Richards Joins Valent BioSciences Corporation as Plant Manager for new Osage Manufacturing Facility

FOR IMMEDIATE RELEASE

OSAGE, IA., October 22, 2013 – Valent BioSciences Corporation (VBC) announced that Karen Richards has joined the company as plant manager for VBC’s state-of-the-art biorational manufacturing facility in Osage, IA. In her new role, Richards will assume responsibility for operations at the $150 million plant, scheduled to come online in the fall of 2014.

VBC is the global leader in the development and commercialization of biorational products, with sales in 95 countries around the world. Biorationals are products typically derived from biological origins that are highly specific in their activity and provide economic, health, and/or environmental benefits. These products include microbial insecticides, fungicides and nematicides as well as plant growth regulators used in seed treatment, production agriculture, postharvest and management of stress in crops.

Richards will report to Tom Green, Vice President, Global Supply Chain and Manufacturing. “Karen comes to VBC with a history of success in several key areas,” Green said. “Her wealth of experience in fermentation technology combined with a demonstrated, results-driven approach to leadership and operational excellence positions VBC well for continued growth in the future.”

Prior to her role at VBC, Richards established a career in manufacturing that included direct responsibility for operations, quality control, engineering, maintenance, planning, buying, and adherence to Environmental Health and Safety Guidelines with one of the world’s leading pharmaceutical manufacturers. Karen earned her BS degree in chemical engineering from Purdue University and holds numerous certifications including Lean and Six Sigma.

“VBC’s investment in Osage is a testament to its commitment to its broad range of customers in agriculture, public health, and forestry around the world,” Richards said. “With accelerated growth forecast for its existing portfolio and several exciting new products in the pipeline, the need for superior manufacturing at VBC has never been greater.” Richards said. “I am excited to join the organization and look forward to helping VBC build on its reputation for producing only the highest quality biorational products.”

VBC has hired a total of 30 employees in Osage thus far. Another 31 employees will be hired over the next few months.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Download Press Release

Ted Melnik Joins Valent BioSciences as Executive Vice President & Chief Operating Officer

FOR IMMEDIATE RELEASE

New hire solidifies VBC and Sumitomo Chemical global strategy to expand the biorational technology and commercial platforms.

LIBERTYVILLE, IL., August 19, 2013 – Valent BioSciences Corporation (VBC) announced that Ted Melnik has joined the company as Executive Vice President & Chief Operating Officer. Beginning August 26, Ted will assume leadership for the day-to-day business operations of VBC including responsibility for achieving its short- and mid- range business plans.

Melnik will report directly to Mike Donaldson, President and Chief Executive Officer of VBC. He joins Andy Lee, Executive Vice President & Chief Operating Officer for Valent U.S.A. Corporation and Roberto Carpentier, Executive Vice President and Chief Operating Officer of Pace International as recent additions to the Sumitomo and VBC Management team. Melnik fills a position that was envisioned in 2009 when Donaldson’s responsibilities expanded to include leadership of Sumitomo Chemical’s Health and Crop Sciences companies in NAFTA and Latin America, as well as his continuing role as Executive Officer at SCC in Tokyo.

According to Donaldson, Melnik’s history of innovation and leadership in biorational development for agriculture align well with the company’s future growth expectations. “Ted’s experience and first-hand knowledge of the biorationals business and industry make him an excellent fit for this important position,” Donaldson said. “The business models of VBC, Valent U.S.A. and Pace International each have unique requirements and roles within the global SCC agricultural market segments. Ted’s addition will allow for increased collaboration and synergies between all SCC Regional affiliate companies worldwide, including both conventional and biorational crop production solutions.”

Melnik comes to VBC with more than thirty years of experience including leadership positions with both biorational and conventional chemistry companies. In 2001, Melnik was named President of the newly created Novozymes Biologicals Inc., a position he held until 2010. Melnik has a proven track record of leadership in global business management, operations, acquisitions and integrations, marketing, and new product development. He also has significant experience in the management of biological manufacturing operations and will play a key role in overseeing the commissioning of VBC’s new $150 million biorational manufacturing facility in Osage, Iowa, that will come on line in 2014.

“I am excited about the opportunities for VBC as well as the other Sumitomo Chemical affiliate companies around the world,” Melnik said. “With its continually expanding portfolio of innovative and high quality products, VBC has strengthened its position as the worldwide leader in the development and commercialization of biorationals. VBC’s recent acquisition of Pace International for postharvest solutions and the construction of its new biorational manufacturing plant in Osage, Iowa are testaments to the company’s success, the vision of its leadership, and its commitment to its partners and customers worldwide.”

VBC is the leader in developing and commercializing biorational products in 95 countries around the world. Biorationals are products typically derived from biological origins (natural or synthesized) that are highly specific in their activity while providing economic, health, and/or environmental benefits. These products include microbial insecticides, fungicides and nematicides, as well as plant growth regulators used in seed treatment, production agriculture, postharvest and management of stress in crops.

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of basic chemicals, petrochemicals, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated net sales for fiscal year 2012 were JPY 1.95 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. For more information about Valent U.S.A. Corporation or our full product line, please call 800-6- VALENT (682-5368) or visit www.valent.com.

About Pace International, LLC
Pace International, LLC collaborates with growers, packers and agricultural organizations to develop innovative solutions to enhance, protect, and preserve fruit and vegetable quality. Pace is the leading provider of post-harvest solutions and technologies, equipment and technical services to maximize efficiencies in packing operations and increase the value of crops being processed. Pace International, LLC is headquartered in Seattle, Washington, USA with R&D, Manufacturing and Administration in Wapato, WA and Sales and Technical Service Offices around the world. For more information, visit http://www.paceint.com

Media Contact:
Rick Melnick
Valent BioSciences Corporation 847-968-4780
Email: rick.melnick@valentbiosciences.com

Download Press Release